發(fā)布時(shí)間：2018-04-18 15:59

  本文選題：屈光參差 + 致病基因��； 參考：《浙江大學(xué)》2015年博士論文

【摘要】：研究背景近視性高度屈光參差指雙眼近視度高度不等,可誘發(fā)斜視、弱視及立體視功能障礙影響患者生活。該疾病發(fā)病隱匿,易造成較高度數(shù)眼視功能不可逆喪失。近視性高度屈光參差以雙眼軸過(guò)度及不對(duì)稱發(fā)育為特征,有一定遺傳傾向性,目前尚無(wú)相關(guān)致病基因報(bào)道。本課題組在臨床工作中密切關(guān)注該疾病患者,并收集了2個(gè)近視性高度屈光參差家系,對(duì)其中一個(gè)家系所有參與研究成員進(jìn)行全面的眼科檢查后發(fā)現(xiàn)所有患者右眼近視度數(shù)、眼軸長(zhǎng)度及前房深度均高于左眼。該研究結(jié)果已于2012年在Optometry Vision Science上發(fā)表。課題組通過(guò)對(duì)致病基因和突變位點(diǎn)的篩選及定位,發(fā)現(xiàn)基因UNC5D是近視性高度屈光參差發(fā)生的易感基因,家系中所有5名患者UNC5D基因上第8個(gè)外顯子中存在一處錯(cuò)義突變,導(dǎo)致蛋白質(zhì)第433位精氨酸(Arg, R)被半胱氨酸(Cys, C)所替代。本研究擬通過(guò)突變型UNC5D基因體外克隆,探索該突變引起的相關(guān)基因表達(dá)差異及人成纖維細(xì)胞外基質(zhì)成分變化的機(jī)制。研究目的本研究通過(guò)對(duì)突變型UNC5D引起相關(guān)基因表達(dá)差異及人成纖維細(xì)胞外基質(zhì)成分變化機(jī)制的研究,推測(cè)UNC5D基因突變可能引起鞏膜外細(xì)胞基質(zhì)成分變化從而導(dǎo)致鞏膜變薄,眼軸過(guò)度增長(zhǎng)的發(fā)生機(jī)制,為深入研究突變型UNC5D基因?qū)е陆曅郧鈪⒉钛圯S不對(duì)稱及過(guò)度發(fā)育的發(fā)病機(jī)理奠定基礎(chǔ)。研究方法1應(yīng)用生物信息學(xué)方法對(duì)突變蛋白結(jié)構(gòu)及功能進(jìn)行計(jì)算機(jī)分析與預(yù)測(cè),初步判斷突變對(duì)蛋白結(jié)構(gòu)及功能的影響。(1)采用蛋白質(zhì)疏水性分析(Kyte Doolittle Hydropathy Plots)軟件對(duì)突變?cè)斐傻牡鞍踪|(zhì)疏水性質(zhì)的改變進(jìn)行初步分析。(2)分別采用表型多態(tài)性分析(Polymorphism phenotypin v2, PolyPhen-2),格蘭瑟姆得分差異(Granthem score difference, Align-GVGD),氨基酸替換損害性排序程序(Sorting Intolerant From Tolerant amino acid substitutions, SIFT)軟件預(yù)測(cè)突變對(duì)蛋白功能的影響。2全基因合成野生型人UNC5D基因,利用DNA體外重組技術(shù)和PCR介導(dǎo)的定點(diǎn)誘變技術(shù),構(gòu)建野生型和突變型UNC5D基因Tet-on四環(huán)素調(diào)控慢病毒真核表達(dá)載體系統(tǒng),分別與Tet-on調(diào)控元件共同感染HEK293T細(xì)胞,強(qiáng)力霉素(Doxycycline)誘導(dǎo)野生型和突變型UNC5D基因表達(dá)。提取誘導(dǎo)表達(dá)后野生組、突變組和未誘導(dǎo)組HEK293T細(xì)胞總RNA于Affymetrix 3' IVT芯片平臺(tái)進(jìn)行mRNA表達(dá)譜芯片檢測(cè),采用實(shí)時(shí)熒光定量PCR技術(shù)驗(yàn)證野生組、突變組及未誘導(dǎo)組HSPA6基因的表達(dá)差異。3構(gòu)建含HA標(biāo)簽的野生型和突變型UNC5D基因pLVX-IRES-ZsGreenl'慢病毒真核表達(dá)載體,感染人真皮成纖維細(xì)胞(HDFs)。(1)采用實(shí)時(shí)熒光定量PCR技術(shù)驗(yàn)證野生組、突變組及對(duì)照組(空載體組)HSPA6基因的表達(dá)差異；(2)采用倒置熒光顯微鏡觀察野生組和突變組UNC5D基因亞細(xì)胞定位差異；(3)采用免疫共沉淀技術(shù)檢測(cè)HSP70B’蛋白與Smad2/3蛋白間相互作用；(4)TGF-β1處理野生組、突變組及對(duì)照組細(xì)胞,采用qPCR檢測(cè)各組細(xì)胞COL1A1、MMP-1和MMP-2的mRNA水平表達(dá)差異,并以Western Blot驗(yàn)證COL1A1蛋白水平表達(dá)差異；(5)TGF-β1處理野生組、突變組及對(duì)照組細(xì)胞,采用Western Blot檢測(cè)野生組和突變組Smad2/3蛋白磷酸化水平。研究結(jié)果1生物信息學(xué)方法對(duì)突變蛋白結(jié)構(gòu)及功能分析與預(yù)測(cè)結(jié)果：(1)蛋白質(zhì)疏水性分析提示：UNC5D蛋白第433位氨基酸由精氨酸突變?yōu)榘腚装彼?氨基酸由強(qiáng)親水性突變?yōu)槭杷?造成突變型UNC5D蛋白該區(qū)域疏水性較野生型明顯升高(2)分別采用表型多態(tài)性分析、格蘭瑟姆得分差異及氨基酸替換損害性排序程序軟件預(yù)測(cè)提示：突變極有可能損害蛋白功能。2成功構(gòu)建野生型和突變型UNC5D基因Tet-on四環(huán)素調(diào)控慢病毒真核表達(dá)載體系統(tǒng)感染HEK293T細(xì)胞,野生型和突變型UNC5D基因Dox誘導(dǎo)表達(dá)成功。Affymetrix 3'IVT芯片平臺(tái)mRNA表達(dá)譜芯片檢測(cè)結(jié)果提示在mRNA水平突變組較野生組有15個(gè)基因表達(dá)上調(diào),2個(gè)基因表達(dá)下調(diào),其中HSPA6基因較野生組上調(diào)22.08倍,突變組HSPA6基因較未誘導(dǎo)組上調(diào)27.58倍,野生組較未誘導(dǎo)組HSPA6基因表達(dá)無(wú)差異。qPCR對(duì)HSPA6基因在各組表達(dá)差異驗(yàn)證結(jié)果與芯片檢測(cè)結(jié)果趨勢(shì)基本一致：突變組HSPA6基因相對(duì)表達(dá)量高于野生組7.82倍,高于未誘導(dǎo)組25.16倍,野生組HSPA6相對(duì)表達(dá)量高于未誘導(dǎo)組3.22倍,。3成功構(gòu)建含HA標(biāo)簽的野生型和突變型UNC5D基因慢病毒真核表達(dá)載體pLVX-IRES-ZsGreenl感染人成纖維細(xì)胞。(1)qPCR驗(yàn)證野生組、突變組及對(duì)照組入成纖維細(xì)胞HSPA6基因表達(dá)差異提示：突變組HSPA6基因高于野生組6.02倍,突變組HSPA6基因高于對(duì)照組15.59倍,野生組HSPA6高于對(duì)照組2.59倍。(2)倒置熒光顯微鏡觀察野生組和突變組人成纖維細(xì)胞UNC5D基因亞細(xì)胞定位未見(jiàn)明顯差異。(3)免疫共沉淀結(jié)果提示突變組高表達(dá)的HSP70B'蛋白與Smad2/3蛋白間存在相互作用。(4) TGF-β1處理野生組、突變組及對(duì)照組細(xì)胞,qPCR檢測(cè)發(fā)現(xiàn)突變組COL1A1較其他兩組表達(dá)下調(diào),MMP-2表達(dá)上調(diào),MMP-1表達(dá)無(wú)顯著差異,Western Blot亦提示突變組COL1A1蛋白表達(dá)低于較其他兩組；(5)TGF-β1處理野生組、突變組及對(duì)照組細(xì)胞,Western Blot提示突變組Smad2/3蛋白磷酸化水平低于野生組。研究結(jié)論本研究發(fā)現(xiàn)突變型UNC5D基因可顯著上調(diào)HSPA6基因表達(dá),降低Smad2/3蛋白磷酸化水平,干擾TGF-β信號(hào)轉(zhuǎn)導(dǎo),導(dǎo)致人成纖維細(xì)胞外基質(zhì)成分變化,推測(cè)該突變可引起鞏膜成纖維細(xì)胞外基質(zhì)成分變化,導(dǎo)致鞏膜重建進(jìn)而影響眼軸的發(fā)育,首次為近視性屈光參差相關(guān)致病基因的機(jī)制研究提供依據(jù)。
[Abstract]:On the background of high myopic anisometropia in the eyes of myopia with different height, can be induced by strabismus, amblyopia and stereopsis dysfunction in patients with the disease. Life affects the incidence of occult, caused by the high degree of visual function in eyes. The irreversible loss of high myopic anisometropia on binocular shaft and asymmetric characteristics of development, have a certain genetic predisposition at present, there is no related genes reported. The research group in clinical work, pay close attention to the disease, and collected 2 high myopic anisometropia family, one of the family members were all involved in the study of comprehensive eye examination found that all patients with right eye myopia, axial length and anterior chamber depth above the left eye. The results of the research have been published in the Optometry Vision Science in 2012. By the research group of pathogenic genes and mutation screening and localization, gene UNC 5D is susceptible to high myopic anisometropia occurred in the gene family of all 5 patients on the eighth exons of UNC5D gene a missense mutation exists in 433rd lead to protein arginine (Arg, R) (Cys, C) is a cysteine substitution. This study by mutant UNC5D in vitro gene cloning, explore the mutation gene expression caused by the differences and changes in fiber composition of the extracellular matrix. The mechanism of induced gene expression profiles of human fibroblast and extracellular matrix components change mechanism research on mutant UNC5D research purpose through this study, we speculated that UNC5D gene mutation can cause changes of scleral matrix composition cells resulting in scleral thinning, mechanism of axial excessive growth, for the further study of mutant UNC5D gene causes myopic anisometropia axial asymmetry and the excessive development of the pathogenesis of Dian Dingji research foundation. Methods 1 by bioinformatics analysis and prediction of protein structure and function of the computer, to determine the initial impact of the mutation on protein structure and function. (1) the analysis of protein hydrophobicity (Kyte Doolittle Hydropathy Plots) software to change the protein hydrophobicity caused by mutations were analyzed (2) were used. Analysis of phenotypic polymorphism (Polymorphism phenotypin V2, PolyPhen-2), Grantham (Granthem score difference, scores of Align-GVGD), amino acid substitution damage (Sorting Intolerant From Tolerant program amino acid substitutions SIFT) software to predict the mutation in the.2 gene synthesis of wild type UNC5D gene affect protein function, using site directed mutagenesis of DNA in vitro recombinant technology and PCR mediated, construction of wild type and mutant UNC5D gene Tet-on four cyclophilin control lentiviral eukaryotic expression As the carrier system, and regulatory elements of Tet-on co infected HEK293T cells, doxycycline (Doxycycline) induced by wild type and mutant UNC5D gene expression. The extraction of induced mutation group and wild group, non induced group HEK293T cell total RNA in Affymetrix 3'IVT chip platform mRNA microarray detection, using real-time fluorescence quantitative PCR technology verify the wild group, mutation and expression of group differences in the non induced group HSPA6 gene.3 was constructed with HA tag wild type and mutation type UNC5D gene pLVX-IRES-ZsGreenl' lentiviral eukaryotic expression vector infection of human dermal fibroblasts (HDFs). (1) by using real-time quantitative PCR technology to verify the wild group, control group and mutation group (vector group) HSPA6 gene differential expression; (2) using the inverted fluorescence microscope and UNC5D gene mutation group and wild group differences in subcellular localization; (3) by immunoprecipitation. The interaction was detected HSP70B protein and Smad2/3 protein; (4) TGF- beta 1 treatment group and control group of wild and mutant cells were detected by qPCR, cell COL1A1, the differential expression of MMP-1 and MMP-2 levels of mRNA, Western and Blot to verify the COL1A1 protein expression differences; (5) TGF- beta 1 treatment of wild group and control group, mutant cells group, using Western Blot to detect wild group and mutation group Smad2/3 protein phosphorylation level. The results of 1 methods of bioinformatics analysis and mutation of protein structure and function prediction results: (1) protein hydrophobicity analysis showed that UNC5D protein of 433rd amino acid mutation from arginine to cysteine. The amino acid mutation from hydrophilic to hydrophobic, causing mutant UNC5D protein the hydrophobic region compared to the wild type was significantly increased (2) were analyzed by phenotypic polymorphism, Grantham scores and amino acid substitution The damage of sorting program software to predict the likely damage tip: mutation.2 protein function construct of wild-type and mutant UNC5D gene Tet-on tetracycline regulated lentiviral eukaryotic expression vector system infected HEK293T cells, wild-type and mutant UNC5D gene expression induced by Dox.Affymetrix 3'IVT chip platform mRNA expression detection results suggest that at the level of mRNA mutation group a group of wild expression of 15 genes microarray, 2 genes down regulated the expression of the HSPA6 gene than the wild group increased 22.08 times, HSPA6 gene mutation group than non induced group increased 27.58 times, wild group than in the non induced group HSPA6 gene.QPCR expression was no significant difference of HSPA6 gene expression test results between the results and the chip basically the same trend in each group: the relative expression of HSPA6 gene mutation group was higher than the wild group 7.82 times, 25.16 times higher than that of non induced group, HSPA6 group of wild relative table As the amount of higher than non induced group 3.22 times,.3 successfully constructed HA tag containing wild type and mutant UNC5D gene lentiviral eukaryotic expression vector of pLVX-IRES-ZsGreenl infection in human fibroblasts. (1) qPCR verification wild group and mutation group and control group in fibroblast cells HSPA6 gene expression in HSPA6 gene mutation group was higher than that of Tip: the wild group 6.02 times, HSPA6 gene mutation group was higher than that of group 15.59 times that of the control group was higher than that of wild HSPA6 2.59 fold of control group. (2) under the inverted fluorescence microscope wild-type UNC5D gene in fibroblasts of subcellular localization showed no significant difference between the group and mutation (3). The results suggest the presence of interacting mutation group high expression of HSP70B'protein and Smad2/3 protein co immunoprecipitation. (4) TGF- beta 1 treatment group and control group of wild and mutant cells, detection of qPCR mutation was found in group COL1A1 than the other two groups of expression of MMP-2 expression, MMP-1 expression was not significantly The difference, Western Blot also indicated that the mutation group of COL1A1 protein was lower than that in the other two groups; (5) TGF- beta 1 treatment group and control group of wild and mutant cells group, Western Blot group suggested that the mutant phosphorylation of Smad2/3 protein than the wild group. Conclusions this study found that the mutant UNC5D gene can up regulate the expression of HSPA6 gene. Reduce the level of Smad2/3 protein phosphorylation, interference of TGF- beta signaling, leads to changes of fibroblast extracellular matrix components, speculated that the mutation can cause scleral changes of fibroblast extracellular matrix, thereby affecting the axial lead of scleral reconstruction development, provide the basis for the first time to study the mechanism of myopic anisometropia related genes.

【學(xué)位授予單位】：浙江大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2015
【分類(lèi)號(hào)】：R777.44

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張怡紅,吳玉潭,李仙芝,王振東;準(zhǔn)分子激光原位角膜磨鑲術(shù)矯治屈光參差后的立體視覺(jué)[J];中國(guó)斜視與小兒眼科雜志;2002年04期

2 蔣金康;眼的屈光參差及其矯正[J];中國(guó)眼鏡科技雜志;2002年02期

3 羅雄偉;陳玲;王清;麥土興;;準(zhǔn)分子激光原位角膜磨鑲術(shù)治療兒童單眼高度屈光參差的效果觀察及護(hù)理[J];廣東醫(yī)學(xué)院學(xué)報(bào);2010年03期

4 劉洪香;;分析眼屈光參差的癥狀及治療[J];價(jià)值工程;2011年02期

5 楊紅;趙為民;;病理性屈光參差患者的視力分析[J];中國(guó)醫(yī)藥指南;2011年28期

6 武國(guó)恩,徐寶萃,孟祥成;矯正屈光參差前后的視功能觀察[J];實(shí)用眼科雜志;1984年04期

7 霍純信;小兒屈光參差的矯正及注意[J];實(shí)用眼科雜志;1988年10期

8 肖國(guó)士;什么叫屈光參差[J];中國(guó)眼鏡科技雜志;1993年01期

9 楊筱麗，，孫瑋;角膜接觸鏡矯正屈光參差的臨床報(bào)導(dǎo)[J];眼科新進(jìn)展;1995年02期

10 鄭立冬;如何為屈光參差者配眼鏡[J];中國(guó)眼鏡科技雜志;1997年01期

相關(guān)會(huì)議論文 前7條

1 陳曦;楊路;余騰;;屈光參差相關(guān)因素分析[A];中華醫(yī)學(xué)會(huì)第十二屆全國(guó)眼科學(xué)術(shù)大會(huì)論文匯編[C];2007年

2 任力蒙;;屈光參差性近視的病因?qū)W調(diào)查[A];中華醫(yī)學(xué)會(huì)第十二屆全國(guó)眼科學(xué)術(shù)大會(huì)論文匯編[C];2007年

3 查桂平;呂帆;陳潔;;不等像與屈光參差及視疲勞相關(guān)性的臨床研究[A];2008年浙江省眼科學(xué)術(shù)會(huì)議論文集[C];2008年

4 何青;徐國(guó)興;郭健;王斌;楊蕾;陳雪君;黃巧珍;;屈光參差與主導(dǎo)眼的相關(guān)性研究[A];第十屆全國(guó)中西醫(yī)結(jié)合眼科學(xué)術(shù)會(huì)議暨第五屆海峽眼科學(xué)術(shù)交流會(huì)論文匯編[C];2011年

5 羅啟惠;汪輝;任茜;胡春明;;兒童嚴(yán)重屈光參差性遠(yuǎn)視二次LASIK手術(shù)1例[A];中華醫(yī)學(xué)會(huì)第十二屆全國(guó)眼科學(xué)術(shù)大會(huì)論文匯編[C];2007年

6 葉曉玲;;中年人近視行準(zhǔn)分子激光原位角膜磨鑲術(shù)的護(hù)理[A];2006年浙江省眼科學(xué)術(shù)會(huì)議論文集[C];2006年

7 宋峰偉;孫朝暉;;屈光參差程度與視網(wǎng)膜中心抑制、BCVA的相關(guān)性[A];2011年浙江省眼科學(xué)術(shù)會(huì)議論文集[C];2011年

相關(guān)重要報(bào)紙文章 前1條

1 吳翠秀;雙眼視力相差大有什么危害[N];大眾衛(wèi)生報(bào);2006年

相關(guān)博士學(xué)位論文 前1條

1 李丹;突變型UNC5D在近視性高度屈光參差發(fā)病中的機(jī)制研究[D];浙江大學(xué);2015年

相關(guān)碩士學(xué)位論文 前6條

1 郁昕;調(diào)節(jié)性內(nèi)斜視兒童的屈光變化趨勢(shì)和立體視發(fā)展的臨床研究[D];山西醫(yī)科大學(xué);2015年

2 梁蕙;近視性屈光參差對(duì)雙眼協(xié)動(dòng)參數(shù)的影響[D];天津醫(yī)科大學(xué);2010年

3 王海英;屈光參差的生物學(xué)參數(shù)及視功能的調(diào)查研究[D];天津醫(yī)科大學(xué);2006年

4 劉艷;屈光參差與不等像及立體視的關(guān)系及影響因素研究[D];青島大學(xué);2005年

5 馮強(qiáng);3～15歲天津某區(qū)兒童屈光參差流行病學(xué)調(diào)查分析[D];天津醫(yī)科大學(xué);2006年

6 趙華軒;OSAHS人群睡眠姿勢(shì)與屈光參差的關(guān)系及MMP-2、MMP-9在慢性間斷性缺氧小鼠角膜、鞏膜的表達(dá)和意義[D];福建醫(yī)科大學(xué);2014年

本文編號(hào)：1769058